Report cover image

Global Desloratadine Tablets Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 115 Pages
SKU # APRC20340367

Description

Summary

According to APO Research, The global Desloratadine Tablets market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Desloratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Desloratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Desloratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Desloratadine Tablets include Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical, Yangtze River Pharmaceutical Group, Shenzhen Salubris Pharmaceuticals, Guangdong Jiuming pharmaceutical, Yingtai Pharma, Poly Pharm, Sinopharm Group Pharmaceuticals, FangYuan Pharmaceutical and Torrent Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Desloratadine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desloratadine Tablets.

The Desloratadine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Desloratadine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Desloratadine Tablets Segment by Company

Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
Yangtze River Pharmaceutical Group
Shenzhen Salubris Pharmaceuticals
Guangdong Jiuming pharmaceutical
Yingtai Pharma
Poly Pharm
Sinopharm Group Pharmaceuticals
FangYuan Pharmaceutical
Torrent Pharmaceuticals
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
Sandoz International GmbH
Perrigo Company plc
Organon Pharma
Mylan
Glenmark Pharmaceuticals
Dr. Reddy's Laboratories
Apotex
Desloratadine Tablets Segment by Type

Ordinary Tablets
Dispersible Tablets
Other
Desloratadine Tablets Segment by Application

Specialist Medical Centre
Hospital and Clinic
Retail Pharmacies
Other
Desloratadine Tablets Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desloratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Desloratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desloratadine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Desloratadine Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Desloratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

115 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Desloratadine Tablets Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Desloratadine Tablets Sales Estimates and Forecasts (2020-2031)
1.3 Desloratadine Tablets Market by Type
1.3.1 Ordinary Tablets
1.3.2 Dispersible Tablets
1.3.3 Other
1.4 Global Desloratadine Tablets Market Size by Type
1.4.1 Global Desloratadine Tablets Market Size Overview by Type (2020-2031)
1.4.2 Global Desloratadine Tablets Historic Market Size Review by Type (2020-2025)
1.4.3 Global Desloratadine Tablets Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Desloratadine Tablets Sales Breakdown by Type (2020-2025)
1.5.2 Europe Desloratadine Tablets Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Desloratadine Tablets Sales Breakdown by Type (2020-2025)
1.5.4 South America Desloratadine Tablets Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Desloratadine Tablets Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Desloratadine Tablets Industry Trends
2.2 Desloratadine Tablets Industry Drivers
2.3 Desloratadine Tablets Industry Opportunities and Challenges
2.4 Desloratadine Tablets Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Desloratadine Tablets Revenue (2020-2025)
3.2 Global Top Players by Desloratadine Tablets Sales (2020-2025)
3.3 Global Top Players by Desloratadine Tablets Price (2020-2025)
3.4 Global Desloratadine Tablets Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Desloratadine Tablets Major Company Production Sites & Headquarters
3.6 Global Desloratadine Tablets Company, Product Type & Application
3.7 Global Desloratadine Tablets Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Desloratadine Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Desloratadine Tablets Players Market Share by Revenue in 2024
3.8.3 2023 Desloratadine Tablets Tier 1, Tier 2, and Tier 3
4 Desloratadine Tablets Regional Status and Outlook
4.1 Global Desloratadine Tablets Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Desloratadine Tablets Historic Market Size by Region
4.2.1 Global Desloratadine Tablets Sales in Volume by Region (2020-2025)
4.2.2 Global Desloratadine Tablets Sales in Value by Region (2020-2025)
4.2.3 Global Desloratadine Tablets Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Desloratadine Tablets Forecasted Market Size by Region
4.3.1 Global Desloratadine Tablets Sales in Volume by Region (2026-2031)
4.3.2 Global Desloratadine Tablets Sales in Value by Region (2026-2031)
4.3.3 Global Desloratadine Tablets Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Desloratadine Tablets by Application
5.1 Desloratadine Tablets Market by Application
5.1.1 Specialist Medical Centre
5.1.2 Hospital and Clinic
5.1.3 Retail Pharmacies
5.1.4 Other
5.2 Global Desloratadine Tablets Market Size by Application
5.2.1 Global Desloratadine Tablets Market Size Overview by Application (2020-2031)
5.2.2 Global Desloratadine Tablets Historic Market Size Review by Application (2020-2025)
5.2.3 Global Desloratadine Tablets Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Desloratadine Tablets Sales Breakdown by Application (2020-2025)
5.3.2 Europe Desloratadine Tablets Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Desloratadine Tablets Sales Breakdown by Application (2020-2025)
5.3.4 South America Desloratadine Tablets Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Desloratadine Tablets Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
6.1.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Comapny Information
6.1.2 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Business Overview
6.1.3 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Product Portfolio
6.1.5 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments
6.2 Yangtze River Pharmaceutical Group
6.2.1 Yangtze River Pharmaceutical Group Comapny Information
6.2.2 Yangtze River Pharmaceutical Group Business Overview
6.2.3 Yangtze River Pharmaceutical Group Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yangtze River Pharmaceutical Group Desloratadine Tablets Product Portfolio
6.2.5 Yangtze River Pharmaceutical Group Recent Developments
6.3 Shenzhen Salubris Pharmaceuticals
6.3.1 Shenzhen Salubris Pharmaceuticals Comapny Information
6.3.2 Shenzhen Salubris Pharmaceuticals Business Overview
6.3.3 Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Product Portfolio
6.3.5 Shenzhen Salubris Pharmaceuticals Recent Developments
6.4 Guangdong Jiuming pharmaceutical
6.4.1 Guangdong Jiuming pharmaceutical Comapny Information
6.4.2 Guangdong Jiuming pharmaceutical Business Overview
6.4.3 Guangdong Jiuming pharmaceutical Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Guangdong Jiuming pharmaceutical Desloratadine Tablets Product Portfolio
6.4.5 Guangdong Jiuming pharmaceutical Recent Developments
6.5 Yingtai Pharma
6.5.1 Yingtai Pharma Comapny Information
6.5.2 Yingtai Pharma Business Overview
6.5.3 Yingtai Pharma Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yingtai Pharma Desloratadine Tablets Product Portfolio
6.5.5 Yingtai Pharma Recent Developments
6.6 Poly Pharm
6.6.1 Poly Pharm Comapny Information
6.6.2 Poly Pharm Business Overview
6.6.3 Poly Pharm Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Poly Pharm Desloratadine Tablets Product Portfolio
6.6.5 Poly Pharm Recent Developments
6.7 Sinopharm Group Pharmaceuticals
6.7.1 Sinopharm Group Pharmaceuticals Comapny Information
6.7.2 Sinopharm Group Pharmaceuticals Business Overview
6.7.3 Sinopharm Group Pharmaceuticals Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sinopharm Group Pharmaceuticals Desloratadine Tablets Product Portfolio
6.7.5 Sinopharm Group Pharmaceuticals Recent Developments
6.8 FangYuan Pharmaceutical
6.8.1 FangYuan Pharmaceutical Comapny Information
6.8.2 FangYuan Pharmaceutical Business Overview
6.8.3 FangYuan Pharmaceutical Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 FangYuan Pharmaceutical Desloratadine Tablets Product Portfolio
6.8.5 FangYuan Pharmaceutical Recent Developments
6.9 Torrent Pharmaceuticals
6.9.1 Torrent Pharmaceuticals Comapny Information
6.9.2 Torrent Pharmaceuticals Business Overview
6.9.3 Torrent Pharmaceuticals Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Torrent Pharmaceuticals Desloratadine Tablets Product Portfolio
6.9.5 Torrent Pharmaceuticals Recent Developments
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Comapny Information
6.10.2 Teva Pharmaceutical Industries Business Overview
6.10.3 Teva Pharmaceutical Industries Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceutical Industries Desloratadine Tablets Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Comapny Information
6.11.2 Sun Pharmaceutical Industries Business Overview
6.11.3 Sun Pharmaceutical Industries Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sun Pharmaceutical Industries Desloratadine Tablets Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments
6.12 Sandoz International GmbH
6.12.1 Sandoz International GmbH Comapny Information
6.12.2 Sandoz International GmbH Business Overview
6.12.3 Sandoz International GmbH Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sandoz International GmbH Desloratadine Tablets Product Portfolio
6.12.5 Sandoz International GmbH Recent Developments
6.13 Perrigo Company plc
6.13.1 Perrigo Company plc Comapny Information
6.13.2 Perrigo Company plc Business Overview
6.13.3 Perrigo Company plc Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Perrigo Company plc Desloratadine Tablets Product Portfolio
6.13.5 Perrigo Company plc Recent Developments
6.14 Organon Pharma
6.14.1 Organon Pharma Comapny Information
6.14.2 Organon Pharma Business Overview
6.14.3 Organon Pharma Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Organon Pharma Desloratadine Tablets Product Portfolio
6.14.5 Organon Pharma Recent Developments
6.15 Mylan
6.15.1 Mylan Comapny Information
6.15.2 Mylan Business Overview
6.15.3 Mylan Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Mylan Desloratadine Tablets Product Portfolio
6.15.5 Mylan Recent Developments
6.16 Glenmark Pharmaceuticals
6.16.1 Glenmark Pharmaceuticals Comapny Information
6.16.2 Glenmark Pharmaceuticals Business Overview
6.16.3 Glenmark Pharmaceuticals Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Glenmark Pharmaceuticals Desloratadine Tablets Product Portfolio
6.16.5 Glenmark Pharmaceuticals Recent Developments
6.17 Dr. Reddy's Laboratories
6.17.1 Dr. Reddy's Laboratories Comapny Information
6.17.2 Dr. Reddy's Laboratories Business Overview
6.17.3 Dr. Reddy's Laboratories Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Dr. Reddy's Laboratories Desloratadine Tablets Product Portfolio
6.17.5 Dr. Reddy's Laboratories Recent Developments
6.18 Apotex
6.18.1 Apotex Comapny Information
6.18.2 Apotex Business Overview
6.18.3 Apotex Desloratadine Tablets Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Apotex Desloratadine Tablets Product Portfolio
6.18.5 Apotex Recent Developments
7 North America by Country
7.1 North America Desloratadine Tablets Sales by Country
7.1.1 North America Desloratadine Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Desloratadine Tablets Sales by Country (2020-2025)
7.1.3 North America Desloratadine Tablets Sales Forecast by Country (2026-2031)
7.2 North America Desloratadine Tablets Market Size by Country
7.2.1 North America Desloratadine Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Desloratadine Tablets Market Size by Country (2020-2025)
7.2.3 North America Desloratadine Tablets Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Desloratadine Tablets Sales by Country
8.1.1 Europe Desloratadine Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Desloratadine Tablets Sales by Country (2020-2025)
8.1.3 Europe Desloratadine Tablets Sales Forecast by Country (2026-2031)
8.2 Europe Desloratadine Tablets Market Size by Country
8.2.1 Europe Desloratadine Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Desloratadine Tablets Market Size by Country (2020-2025)
8.2.3 Europe Desloratadine Tablets Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Desloratadine Tablets Sales by Country
9.1.1 Asia-Pacific Desloratadine Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Desloratadine Tablets Sales by Country (2020-2025)
9.1.3 Asia-Pacific Desloratadine Tablets Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Desloratadine Tablets Market Size by Country
9.2.1 Asia-Pacific Desloratadine Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Desloratadine Tablets Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Desloratadine Tablets Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Desloratadine Tablets Sales by Country
10.1.1 South America Desloratadine Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Desloratadine Tablets Sales by Country (2020-2025)
10.1.3 South America Desloratadine Tablets Sales Forecast by Country (2026-2031)
10.2 South America Desloratadine Tablets Market Size by Country
10.2.1 South America Desloratadine Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Desloratadine Tablets Market Size by Country (2020-2025)
10.2.3 South America Desloratadine Tablets Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Desloratadine Tablets Sales by Country
11.1.1 Middle East and Africa Desloratadine Tablets Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Desloratadine Tablets Sales by Country (2020-2025)
11.1.3 Middle East and Africa Desloratadine Tablets Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Desloratadine Tablets Market Size by Country
11.2.1 Middle East and Africa Desloratadine Tablets Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Desloratadine Tablets Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Desloratadine Tablets Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Desloratadine Tablets Value Chain Analysis
12.1.1 Desloratadine Tablets Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Desloratadine Tablets Production Mode & Process
12.2 Desloratadine Tablets Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Desloratadine Tablets Distributors
12.2.3 Desloratadine Tablets Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.